design of immunogenic antigen cocktail via affinity maturation-guided optimization.

Bioinform Adv

Department of Electrical and Computer Engineering, Texas A&M University, College Station, TX 77843, United States.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Summary: The increasing emergence of new virus strains with increased infectiousness necessitates a more proactive approach for effective vaccine design. To achieve this goal, it is critical to shift the vaccine design paradigm from traditional approaches that rely on expert intuition and experimental methods toward data-driven strategies that leverage design and virtual screening. In this work, we propose a computational pipeline for designing an optimized immunogenic cocktail that can boost the immune response. The proposed pipeline consists of two stages, where potential antigen candidates are identified in the first stage, followed by the optimal selection and combination of the candidates in the second stage to maximize the expected immunogenicity. We leverage predictive models trained using deep mutational scanning data to drive the candidate antigen selection process based on three selection criteria-namely, binding affinity between viral protein and receptor, antibody escape probability, and sequence diversity. To identify the optimal cocktail within the pool of selected antigens, we adopt a combinatorial optimization framework, where the cocktail design is iteratively refined based on the expected efficacy predicted by a sequence-based computational model of affinity maturation. Validation of the designed cocktails through structure-based affinity maturation simulation demonstrates the efficacy of the proposed modular framework for designing an optimized immunogenic cocktail.

Availability And Implementation: The code for cocktail design is available in https://github.com/nafizabeer/Antigen_Cocktail_Design.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12360842PMC
http://dx.doi.org/10.1093/bioadv/vbaf182DOI Listing

Publication Analysis

Top Keywords

vaccine design
8
designing optimized
8
optimized immunogenic
8
cocktail design
8
affinity maturation
8
design
6
cocktail
5
design immunogenic
4
immunogenic antigen
4
antigen cocktail
4

Similar Publications

Background: We evaluated the effectiveness of the influenza vaccine programme against infection among emergency hospital admissions with respiratory conditions in Northern Ireland during the 2023/2024 influenza season.

Methods: Using a test-negative design, we compared the odds of vaccination between patients who tested positive (cases) and negative (controls) for laboratory-confirmed influenza, adjusting for confounders. VE was stratified by age group, sex and time since vaccination.

View Article and Find Full Text PDF

Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes: An Emulation.

J Am Coll Cardiol

September 2025

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region of China; Advanced Data Analytics for Medical Science Limited, Hong Kong Special Administrative Region of China

Background: There is no consensus for using statins for primary prevention of cardiovascular disease (CVD) and all-cause mortality in adults with type 1 diabetes mellitus (T1DM), because no randomized controlled trial has exclusively investigated statins in this population.

Objectives: In this study, the authors sought to evaluate the long-term risks and benefits of statins for primary prevention in adults with T1DM.

Methods: We performed a sequential target trial emulation comparing statin initiation vs noninitiation using UK primary care data from the IQVIA Medical Research Data database.

View Article and Find Full Text PDF

Pediatric bronchiectasis action management plan to improve clinical outcomes: An RCT.

Chest

September 2025

Child and Maternal Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia; School of Nursing and Midwifery, Charles Darwin University, Darwin, Northern Territory, Australia.

Background: Managing bronchiectasis exacerbations is a priority for patients/parents/caregivers of children with bronchiectasis, yet evidence-based strategies among the pediatric population remain limited.

Research Question: Does the use of a personalized, written bronchiectasis action management plan (BAMP), compared to standard care, reduce non-scheduled doctor visits among children/adolescents with chronic suppurative lung disease (CSLD)/bronchiectasis?

Study Design And Methods: Our multicenter, double-blind, superiority, randomized controlled trial enrolled children from three Australian respiratory departments between June 2018 and December 2020. Children/adolescents aged <19 years with CSLD/bronchiectasis were randomized to receive a personalized BAMP (intervention) or standard care (controls).

View Article and Find Full Text PDF

Pulmonary delivery of small circular RNA vaccines for influenza prevention.

J Control Release

September 2025

Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA; Bioinnovations in Brain Cancer, Biointerfaces Institute; The Developmental Therapeutics Program, Rogel Cancer Center; Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI 48109,

Lipid nanoparticles (LNPs) have played an instrumental role in the delivery of RNA therapeutics and vaccines, including the emerging class of synthetic circular RNA (circRNA). Pulmonary vaccines hold the potential to prevent various respiratory infectious diseases, such as influenza caused by influenza infection. Here, we report the pulmonary delivery of LNPs loaded with highly stable small circRNA vaccine for influenza prevention.

View Article and Find Full Text PDF

Background: The global penetration of mobile phones has offered novel opportunities for communicating health-related information to individuals. A low-cost system that facilitates autonomous communication with individuals via mobile phones holds potential for expanding the reach of health messaging in settings with human resource and infrastructure limitations.

Objective: We sought to design a flexible, low-code system using open-source software that could be adapted to different contexts and technical environments and accommodate a wide range of automation needs.

View Article and Find Full Text PDF